UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of The Securities Exchange Act of
1934
|
Date
of Report (Date of earliest event reported): January
25, 2007
|
Renhuang
Pharmaceuticals, Inc.
(Exact
name of registrant as specified in its charter)
|
Nevada
(State
or other
jurisdiction
of incorporation)
|
|
O-24512
(Commission
File
Number)
|
|
88-1273503
(I.R.S.
Employer
Identification
No.)
|
| |
|
|
|
|
| |
|
|
|
|
|
No.
281, Taiping Road, Taiping District,
Harbin,
Heilongjiang Province, 150050
P.
R. China
(Address
of principal executive offices) (zip code)
|
| |
|
|
|
|
| |
|
|
|
|
|
86-451-5762-0378
(Registrant’s
telephone number, including area code)
|
| |
|
|
|
|
| |
|
|
|
|
|
(Former
name or former address, if changed since last
report.)
|
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
[_]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[_]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[_]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act
(17 CFR 240.14d-2(b))
[_]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act
(17 CFR 240.13e-4(c))
Effective
on January 25, 2007, Edith Kong resigned from her positions as a Director and
our Chief Financial Officer. We are not aware of any disagreements with
Ms. Kong of the type required to be disclosed per Item 5.02(a) of this Form
8-K.
Effective
on January 25, 2007, our Board of Directors hired Mr. Wang Zuoliang as our
interim Chief Financial Officer to replace Ms. Kong. Mr. Wang has served as
Chief Accounting Officer of Harbin Renhuang Pharmaceutical Co. Ltd., our
wholly-owned subsidiary, since 2005. Mr. Wang has more than 10 years experience
in accounting and is familiar with our financial condition and the internal
preparation of our financial statements. From 2004 to 2005, Mr. Wang served
as
the Chief Financial Officer of Harbin Huijiabei Food Co. Ltd. From 2001 to
2004,
Mr. Wang served as the manager of the accounting department of China Resource
Breweries Limited, Harbin Office. Mr. Wang Zuoliang graduated from Qiqihaer
Mechanic Institute in 1994 with a bachelor degree in engineering
management.
We
are in
the process of interviewing candidates for a permanent Chief Financial Officer
and hope to have a new permanent Chief Financial Officer hired in the near
future. Once a new Chief Financial Officer is hired we will file a Form 8-K
with
information regarding the Chief Financial Officer, as required.
Effective
on January 25, 2007, Mr. Pi Dianjun resigned from his position as a Director.
We
are not aware of any disagreements with Mr. Pi Dianjun of the type required
to be disclosed per Item 5.02(a) of this Form 8-K.
Effective
on January 25, 2007, our Board of Directors appointed Mr. Andy Wu to the Board
of Directors as an independent Director and as Chairman of our Audit Committee.
Mr. Wu is currently a Tax Manager at PWC Beijing responsible for the
overall operations of the Dalian office, including IIT filing, tax health check,
assistance on setting up new enterprise/RO, assistance in tax audit defense,
tax
due diligence, tax review for IPO projects, assistance in negotiation for deemed
profit rates, and general tax and business consulting. Mr. Wu has held this
position since January, 2006. During 2005, Mr. Wu was an Assistant Tax Manager
at KPMG Shanghai, with his main responsibilities involving general tax and
business consulting and due diligence work. From August 2004 to March 2005,
Mr.
Wu was a Senior Tax Consultant with Deloitte’s Suzhou Office, primarily
responsible for tax review, Due Diligence, IIT compliance, and general tax
advisory projects. From March 1998 to August 2001, Mr. Wu was the Chief Officer
of the Collections Division for the Nangang Branch of Harbin State Tax Bureau,
where he was responsible for managing the operations of the Collections
Division. Mr. Wu received a Doctorate Finance and Taxation from Xiamen
University in June 2004, a Master in Finance and Taxation from Dongbei
University of Finance in January 2001, and his Bachelor in Taxation from Xiamen
University in July 1992.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
Dated:
January 31, 2007
|
|
Renhuang
Pharmaceuticals, Inc.,
|
| |
|
a
Nevada corporation
|
| |
|
|
| |
|
|
| |
|
/s/
Shaoming Li
|
| |
|
By: Shaoming
Li
|
| |
|
Its: Chief
Executive Officer
|